Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of NERv's Inline Device for the Continuous Monitoring of pH and Conductance Measurements as an Early Diagnostic Method for Anastomotic Leak.

NCT04253028 is registered in ClinicalTrials.gov with FluidAI Medical as lead sponsor.

NCT NCT04253028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04253028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of NERv's Inline Device for the Continuous Monitoring of pH and Conductance Measurements as an Early Diagnostic Method for Anastomotic Leak.
Lead sponsor
FluidAI Medical
Phase
Phase 1
Overall status
Completed
Start date
January 29, 2020
Completion date
March 15, 2020
Enrollment
9 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anastomotic leak